124 related articles for article (PubMed ID: 37622529)
1. Insurance Status is Associated With Recurrence in Cutaneous Head and Neck Squamous Cell Carcinoma.
Victor MT; Zheng W; Park SJ; Jiang SIB; Guo TW
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):132-140. PubMed ID: 37622529
[TBL] [Abstract][Full Text] [Related]
2. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
4. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
5. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of cutaneous squamous cell carcinoma of the head and neck with parotid metastases.
McDowell LJ; Tan TJ; Bressel M; Estall V; Kleid S; Corry J; Johnston ML
J Med Imaging Radiat Oncol; 2016 Oct; 60(5):668-676. PubMed ID: 27324298
[TBL] [Abstract][Full Text] [Related]
8. Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
Melo GM; Guilherme LH; Palumbo MDN; Rosano M; Neves MCD; Callegari FM; Abrahao M; Cervantes O
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S152-S162. PubMed ID: 35042657
[TBL] [Abstract][Full Text] [Related]
9. Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data.
Girardi FM; Wagner VP; Martins MD; Abentroth AL; Hauth LA
Braz J Otorhinolaryngol; 2021; 87(4):389-395. PubMed ID: 31870740
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in patients with head and neck squamous cell carcinoma.
Gourin CG; Podolsky RH
Laryngoscope; 2006 Jul; 116(7):1093-106. PubMed ID: 16826042
[TBL] [Abstract][Full Text] [Related]
11. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tam S; Yao CMKL; Amit M; Gajera M; Luo X; Treistman R; Khanna A; Aashiq M; Nagarajan P; Bell D; El-Naggar A; Migden M; Wong M; Glisson B; Ferrarotto R; Esmaeli B; Rosenthal D; Li G; Weber RS; Myers JN; Gross ND
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):128-135. PubMed ID: 31804658
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma.
Amoils M; Kim J; Lee C; Sunwoo JB; Colevas AD; Aasi SZ; Hollmig ST; Ma Y; Divi V
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):93-99. PubMed ID: 30012051
[TBL] [Abstract][Full Text] [Related]
13. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
[TBL] [Abstract][Full Text] [Related]
14. Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.
Knopf A; Teutsch S; Bier H
BMC Health Serv Res; 2021 Jan; 21(1):45. PubMed ID: 33419421
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes for Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Sullivan CB; Andresen NS; Kendell N; Al-Qurayshi Z; Pagedar NA
Ann Otol Rhinol Laryngol; 2019 Oct; 128(10):949-955. PubMed ID: 31091995
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Head and Neck Microvascular Free Tissue Transfer for Advanced Cutaneous Squamous Cell Carcinoma: A Comparison of Solid Organ Transplant Recipients to Nontransplant Patients.
Wang RY; Gallagher KK; Hernandez DJ; Sandulache VC; Sturgis EM; Huang AT
J Oral Maxillofac Surg; 2024 Mar; 82(3):347-355. PubMed ID: 38103578
[TBL] [Abstract][Full Text] [Related]
18. Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis.
Vasconcelos L; Melo JC; Miot HA; Marques ME; Abbade LP
An Bras Dermatol; 2014; 89(4):562-8. PubMed ID: 25054741
[TBL] [Abstract][Full Text] [Related]
19. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
